Wednesday, December 30, 2009

New cancer treatment

27-year-od Dewi Hermawati is a survivor of a rare type of cancer where the patient suffered from inflammation of the brain. Doctors used an unconventional approach in the management of an inflammation of the brain associated with ovarian tumours. -- ST PHOTO: MUGILAN RAJASEGERAN

DOCTORS in Singapore have come up with a treatment approach for a rare condition associated with ovarian tumour.

They have written a journal article recommending this method as a standard to treat similiar conditions worldwide.

Known as paraneoplastic encephalitis, which is an acute inflammation of the brain, it occurs when there is cancer in the body causing an extremely active immune system to mistakenly attack the brain.

As a result, patients can suffer from neurological complications like fits, confusion or memory problems. If left untreated, this could eventually lead to permanent and severe brain damage or even death.

It is not known how common this condition is as there is no international data. But based on estimates, less than one percent of patients with cancers will have such a condition, said Dr Tan Min-Han, associate consultant at National Cancer Centre Singapore (NCSS)'s department of medical oncology.

The fact that such a condition even exists only came to light in 2007 when a US doctor saw 12 patients who had cancers and were subsequently found to have inflammation of the brain.

Since then, about five patients in Singapore have been diagnosed with the problem.


Saturday, December 26, 2009

Tumours can re-seed themselves

WASHINGTON - TUMOURS can not only spread through the body by sending out tiny cells called seeds, but they can re-seed themselves, researchers said in a report on Thursday that may help explain why tumours grow back even after they are removed.

They said their findings, published in the journal Cell, may also help lead to the development of new drugs to stop the process of cancer spread, or metastasis. 'Circulating tumour cells can also colonise their tumors of origin, in a process that we call 'tumour self-seeding',' Joan Massague of the Memorial Sloan-Kettering Cancer Center in New York and colleagues wrote.

'Now we have found that tumors can recapture some of their most delinquent children, enriching themselves with the most aggressive metastatic cells, enabling them to grow faster and more robustly,' Mr Massague, a Howard Hughes Medical Institute researcher, said in a statement.

'Now we are thinking that in some cases, maybe treatment left inflamed tissue that had been a home for those cells that escaped and were residing somewhere temporarily, perhaps in the bone marrow,' he added. 'They may have re-entered the circulation in the weeks and months after surgery, and now, through the self-seeding process, have homed in on this tissue and reproduced the tumor.'

Mr Massague's team used mice, injecting them with human breast cancer cells that had been genetically engineered with a jellyfish protein to make them glow green under ultraviolet light. They tracked these cells as they spread through the bodies of the mice.

Immune system signaling chemicals, including interleukin 6 and interleukin 8, appear to 'call' the tumor cells home, his team found. -- REUTERS

Wednesday, December 23, 2009